Busy GSK Builds New Relation In Fibrosis And Arthritis

 
• By Kevin Grogan

Deal Snapshot: December is just over a week old but the UK giant has packed a lot in, signing collaborations with likes of Duality Biologics (cancer) and Muna Therapeutics (neurodegeneration). Now it is targeting fibrotic diseases and osteoarthritis after inking a deal with Relation Therapeutics.

The Relation leadership team (L-R): CSO Edith Hessel, COO Benjamin Swerner, head of growth and operations Rosie Rodriguez, CTO Lindsay Edwards and CEO David Roblin (Relation)

More from Deals

More from Immunological